{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:43:25Z","timestamp":1760204605591},"publisher-location":"Vienna","reference-count":23,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783709194676"},{"type":"electronic","value":"9783709194652"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-3-7091-9465-2_19","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T20:56:52Z","timestamp":1343509012000},"page":"107-113","source":"Crossref","is-referenced-by-count":4,"title":["Neuroprotective Efficacy of Microvascularly-Localized Versus Brain-Penetrating Antioxidants"],"prefix":"10.1007","author":[{"given":"Edward D.","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. K.","family":"Andrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Oostveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M.","family":"Scherch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. S.","family":"Lutzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Raub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. S.","family":"Banitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Tustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. L.","family":"Belonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. E.","family":"Ayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0891-5849(91)90152-S","volume":"11","author":"KL Audus","year":"1991","unstructured":"Audus KL, Guillot FL, Braughler JM (1991) Evidence for 21aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Rad Biol Med 11: 361\u2013371","journal-title":"Free Rad Biol Med"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0006-8993(90)91779-G","volume":"532","author":"T Beck","year":"1990","unstructured":"Beck T, Bielenberg GW (1990) Failure of the lipid peroxidation inhibitor U-74006F to improve neurologic outcome after transient forebrain ischemia in the rat. Brain Res 532: 336\u2013338","journal-title":"Brain Res"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0006-8993(91)91226-Q","volume":"560","author":"T Beck","year":"1991","unstructured":"Beck T, Bielenberg GW (1991) The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain Res 560: 159\u2013162","journal-title":"Brain Res"},{"key":"19_CR4","first-page":"6","volume-title":"Central nervous system trauma and stroke: I","author":"JM Braughler","year":"1989","unstructured":"Braughler JM, Hall ED (1989) Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Red Biol Med 6: 289\u2013301"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/jcbfm.1992.35","volume":"12","author":"AM Buchan","year":"1992","unstructured":"Buchan AM, Bruederlin B, Heinicke E, Li H (1992) Failure of the lipid peroxidation inhibitor U-74006F to prevent postischemic selective neuronal injury. J Cereb Blood Flow Metab 12: 250\u2013256","journal-title":"J Cereb Blood Flow Metab"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/01.STR.22.8.1048","volume":"22","author":"JA Clemens","year":"1991","unstructured":"Clemens JA, Ho PPK, Panetta JA (1991) LY178002 reduces rat brain damage after transient global forebrain ischemia. Stroke 22: 1048\u20131052","journal-title":"Stroke"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0891-5849(89)90057-9","volume":"6","author":"ED Hall","year":"1989","unstructured":"Hall ED, Braughler JM (1989) Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation. Free Rad Biol Med 6: 303\u2013313","journal-title":"Free Rad Biol Med"},{"key":"19_CR8","first-page":"688","volume":"258","author":"ED Hall","year":"1991","unstructured":"Hall ED, Braughler JM, Yonkers PA, Smith SL, Linseman KL, Means ED, Scherch HM, Jacobsen EJ, Lahti RA (1991) \u00da78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J Pharmacol Exp Ther 258: 688\u2013694","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1054-3589(08)60497-4","volume":"28","author":"ED Hall","year":"1994","unstructured":"Hall ED, McCall JM, Means ED (1994) Therapeutic potential of the lazaroids (21-aminosteroids) in central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28: 221\u2013268","journal-title":"Adv Pharmacol"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.STR.19.8.997","volume":"19","author":"ED Hall","year":"1988","unstructured":"Hall ED, Pazara KE, Braughler JM (1988) 21-Aminosteroid lipid peroxidation inhibitor U-74006F protects against cerebral ischemia in gerbils. Stroke 19: 997\u20131002","journal-title":"Stroke"},{"key":"19_CR11","first-page":"221","volume":"84","author":"NF Kassell","year":"1996","unstructured":"Kassell NF, Haley EC, Apperson-Hansen C, Alves WM Dovsch NW, Fabinyi G, Matheson J, Reilly P, Siu, K et al. (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A Cooperative Study in Europe, Australia, and NewZealand. J Neurosurg 84: 221\u2013228","journal-title":"Australia, and New Zealand. J Neurosurg"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/01.STR.22.7.896","volume":"22","author":"HJ Lesiuk","year":"1991","unstructured":"Lesiuk HJ, Sutherland GR, Peeling J, Wilkins D, McTavish J, Saunders JK (1991) Effect of U-74006F on forebrain ischemia in rats. Stroke 22: 896\u2013901","journal-title":"Stroke"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4615-7757-7_4","volume":"5","author":"WH Oldendorf","year":"1981","unstructured":"Oldendorf WH (1981) Clearance of radiolabelled substances by brain after arterial injection using a diffusible internal standard. Res Meth Neurochem 5: 91\u2013112","journal-title":"Res Meth Neurochem"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/01.STR.24.5.731","volume":"24","author":"K Pahlmark","year":"1993","unstructured":"Pahlmark K, Folbergrova J, Smith M-L, Siesj\u00f6 BK (1993) Effects of dimethylthiourea on selective neuronal vulnerability in forebrain ischemia in rats. Stroke 24: 731\u2013737","journal-title":"Stroke"},{"issue":"2","key":"19_CR15","first-page":"S138","volume":"11","author":"K Pahlmark","year":"1991","unstructured":"Pahlmark K, Smith ML, Siesj\u00f6 BK (1991) Failure of U-74006F to ameliorate neuronal damage due to transient ischemia or hypoglycemia. J Cereb Blood Flow Metab 11 [Suppl 2]: S138","journal-title":"J Cereb Blood Flow Metab"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0006-8993(94)91649-7","volume":"645","author":"CK Park","year":"1994","unstructured":"Park CK, Hall ED (1994) Dose-response analysis of the 21aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Brain Res 645: 157\u2013163","journal-title":"Brain Res"},{"key":"19_CR17","first-page":"116","volume-title":"Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-aphenylnitrone","author":"JW Phillis","year":"1990","unstructured":"Phillis JW, Clough-Helfman C (1990) Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-aphenylnitrone ( PBN ). Neurosci Lett 116: 315\u2013319"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/jcbfm.1992.10","volume":"12","author":"JHM Prehn","year":"1992","unstructured":"Prehn, JHM, Karkoutly C, Nuglisch J, Peruche B, Krieglstein J (1992) Dihydrolipoate reduces neuronal injury after cerebral ischemia. J Cereb Blood Flow Metab 12: 78\u201387","journal-title":"J Cereb Blood Flow Metab"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/10611869308996085","volume":"1","author":"TJ Raub","year":"1993","unstructured":"Raub TJ, Barsuhn CL, Williams LR, Decker DE, Sawada GA, Ho NFH (1993) Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J Drug Targeting 1: 269\u2013286","journal-title":"J Drug Targeting"},{"key":"19_CR20","first-page":"165","volume":"1","author":"BK Siesj\u00f6","year":"1989","unstructured":"Siesj\u00f6 BK, Agardh C-D, Bengtsson F (1989) Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1: 165\u2013211","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0304-3940(93)90751-6","volume":"149","author":"G Sutherland","year":"1993","unstructured":"Sutherland G, Haas N, Peeling J (1993) Ischemic neocortical protection with U-74006F- a dose-response curve. Neurosci Letts 149: 123\u2013125","journal-title":"Neurosci Letts"},{"key":"19_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/01.STR.23.6.894","volume":"23","author":"D Xue","year":"1992","unstructured":"Xue D, Slivka A, Buchan AM (1992) Tirilazad reduces cortical infarction after transient, but not permanent focal cerebral ischemia in rats. Stroke 23: 894\u2013899","journal-title":"Stroke"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/01.STR.20.3.367","volume":"20","author":"M Zuccarello","year":"1989","unstructured":"Zuccarello M, Anderson DK (1989) Protective effect of a 21aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 20: 367\u2013371","journal-title":"Stroke"}],"container-title":["Mechanisms of Secondary Brain Damage in Cerebral Ischemia and Trauma"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-9465-2_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T10:15:58Z","timestamp":1606126558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-9465-2_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9783709194676","9783709194652"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-9465-2_19","relation":{},"subject":[],"published":{"date-parts":[[1996]]}}}